SG141463A1 - 2-(1h-indolysulfanyl)-benzyl amine derivatives as ssri - Google Patents
2-(1h-indolysulfanyl)-benzyl amine derivatives as ssriInfo
- Publication number
- SG141463A1 SG141463A1 SG200802454-9A SG2008024549A SG141463A1 SG 141463 A1 SG141463 A1 SG 141463A1 SG 2008024549 A SG2008024549 A SG 2008024549A SG 141463 A1 SG141463 A1 SG 141463A1
- Authority
- SG
- Singapore
- Prior art keywords
- ssri
- benzyl amine
- amine derivatives
- indolysulfanyl
- reuptake inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301923 | 2003-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG141463A1 true SG141463A1 (en) | 2008-04-28 |
Family
ID=36603121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200802454-9A SG141463A1 (en) | 2003-12-23 | 2004-12-21 | 2-(1h-indolysulfanyl)-benzyl amine derivatives as ssri |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1860100B1 (zh) |
| KR (2) | KR20080092471A (zh) |
| CN (2) | CN101372474A (zh) |
| AR (1) | AR046978A1 (zh) |
| AT (1) | ATE500220T1 (zh) |
| CA (1) | CA2551168C (zh) |
| DE (1) | DE602004031680D1 (zh) |
| DK (1) | DK1860100T3 (zh) |
| EA (2) | EA010666B1 (zh) |
| ES (1) | ES2362237T3 (zh) |
| HK (1) | HK1103075A1 (zh) |
| IS (2) | IS2551B (zh) |
| ME (1) | ME01040B (zh) |
| MY (1) | MY143038A (zh) |
| NO (1) | NO336676B1 (zh) |
| NZ (1) | NZ547046A (zh) |
| PL (1) | PL1860100T4 (zh) |
| PT (1) | PT1860100E (zh) |
| RS (1) | RS51899B (zh) |
| SG (1) | SG141463A1 (zh) |
| SI (1) | SI1860100T1 (zh) |
| TW (1) | TWI347183B (zh) |
| UA (1) | UA82920C2 (zh) |
| ZA (1) | ZA200705870B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101224201B (zh) * | 2007-01-18 | 2011-10-05 | 和泓生物技术（上海）有限公司 | 多巴胺转运蛋白和去甲肾上腺素转运蛋白双重抑制剂的应用 |
| CN103201262B (zh) * | 2010-08-20 | 2016-06-01 | 艾米拉医药股份有限公司 | 自分泌运动因子抑制剂及其用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3803143A (en) | 1969-09-08 | 1974-04-09 | Eisai Co Ltd | 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines |
| US4018830A (en) | 1969-09-22 | 1977-04-19 | Merck & Co., Inc. | Phenylthioaralkylamines |
| US4055665A (en) | 1974-11-25 | 1977-10-25 | Merck & Co., Inc. | Treating arrythmia with phenylthioaralkylamines |
| US4056632A (en) | 1975-07-21 | 1977-11-01 | Burroughs Wellcome Co. | 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use |
| EP0396827A1 (en) | 1989-05-09 | 1990-11-14 | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu | 2-Phenylthiobenzylamine dervivatives and acid addition salts thereof |
| GB8912971D0 (en) | 1989-06-06 | 1989-07-26 | Wellcome Found | Halogen substituted diphenylsulfides |
| GB9126311D0 (en) | 1991-12-11 | 1992-02-12 | Wellcome Found | Substituted diphenylsulfides |
| CZ293595A3 (cs) | 1995-11-09 | 1999-12-15 | Farmak A. S. | Deriváty N,N-dimethyl-2-(arylthio)benzylaminu, jejich soli, způsoby jejich přípravy a jejich použití v léčivých přípravcích |
| US5912256A (en) * | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| JP2000516936A (ja) * | 1996-08-27 | 2000-12-19 | アメリカン・ホーム・プロダクツ・コーポレイション | ドパミンｄ２作動薬としておよび５―ｈｔ１ａリガンドとしての４―アミノエトキシインドール |
| ES2264259T3 (es) | 1999-04-30 | 2006-12-16 | Trustees Of The University Of Pennsylvania | Agentes de obtencion de imagenes por spect (tomografia por emision de foton unico) para transportador de serotonina. |
| US6410736B1 (en) | 1999-11-29 | 2002-06-25 | Pfizer Inc. | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| US6436938B1 (en) | 2001-01-22 | 2002-08-20 | Pfizer Inc. | Combination treatment for depression |
-
2004
- 2004-12-16 TW TW093139107A patent/TWI347183B/zh not_active IP Right Cessation
- 2004-12-21 DK DK07017638.3T patent/DK1860100T3/da active
- 2004-12-21 CN CNA2008101447939A patent/CN101372474A/zh active Pending
- 2004-12-21 ZA ZA200705870A patent/ZA200705870B/xx unknown
- 2004-12-21 PT PT07017638T patent/PT1860100E/pt unknown
- 2004-12-21 KR KR1020087021534A patent/KR20080092471A/ko not_active Application Discontinuation
- 2004-12-21 KR KR1020067011175A patent/KR100872022B1/ko active IP Right Grant
- 2004-12-21 MY MYPI20045285A patent/MY143038A/en unknown
- 2004-12-21 CN CN200480038470A patent/CN100591666C/zh not_active Expired - Fee Related
- 2004-12-21 SG SG200802454-9A patent/SG141463A1/en unknown
- 2004-12-21 EA EA200601226A patent/EA010666B1/ru not_active IP Right Cessation
- 2004-12-21 AR ARP040104830A patent/AR046978A1/es not_active Application Discontinuation
- 2004-12-21 DE DE602004031680T patent/DE602004031680D1/de active Active
- 2004-12-21 ES ES07017638T patent/ES2362237T3/es active Active
- 2004-12-21 AT AT07017638T patent/ATE500220T1/de active
- 2004-12-21 UA UAA200607149A patent/UA82920C2/uk unknown
- 2004-12-21 EP EP07017638A patent/EP1860100B1/en active Active
- 2004-12-21 CA CA2551168A patent/CA2551168C/en not_active Expired - Fee Related
- 2004-12-21 PL PL07017638T patent/PL1860100T4/pl unknown
- 2004-12-21 ME MEP-2008-66A patent/ME01040B/me unknown
- 2004-12-21 EA EA200702258A patent/EA012752B1/ru not_active IP Right Cessation
- 2004-12-21 SI SI200431671T patent/SI1860100T1/sl unknown
- 2004-12-21 RS RS20110213A patent/RS51899B/en unknown
- 2004-12-21 NZ NZ547046A patent/NZ547046A/en not_active IP Right Cessation
-
2006
- 2006-05-15 IS IS8467A patent/IS2551B/is unknown
- 2006-07-24 NO NO20063405A patent/NO336676B1/no not_active IP Right Cessation
-
2007
- 2007-07-13 HK HK07107553.7A patent/HK1103075A1/xx not_active IP Right Cessation
-
2009
- 2009-06-05 IS IS8827A patent/IS2815B/is unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL176111A0 (en) | 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri | |
| MEP6508A (xx) | Fenil-piperazin derivati kao inhibitori resorbucije serotonina | |
| NO20066010L (no) | 2-(1h-indolylsulfanyl)-aryl-aminderivater for anvendelse i behandlingen av affektive lidelser, smerte, adhd og stressurininkontinens | |
| MX2009012608A (es) | Compuestos de hidroxietil amina substituidos como moduladores de beta-secretasa y metodos de uso. | |
| HRP20080478T3 (en) | 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors | |
| YU21602A (sh) | Derivati biaril etra korisni kao inhibitori ponovnog podizanja monoamina | |
| MXPA06012640A (es) | Compuestos de morfolina. | |
| MY150448A (en) | 1- [2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition | |
| EA200801488A1 (ru) | Замещенные фенетиламины, обладающие серотонинергической и/или норэпинефринергической активностью | |
| JO3440B1 (ar) | استخدام الأغوميلاتين في تحضير علاجات لمداولة اضطرابات القلق العام. | |
| NZ595569A (en) | Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators | |
| NZ597433A (en) | 3-phenoxymethylpyrrolidine compounds | |
| IN2012DN03844A (zh) | ||
| TW200631582A (en) | Therapeutic pyrazolo [3, 4-b] pyridines and indazoles | |
| ATE455091T1 (de) | Para-alkyl-substituierte n-(4-hydroxy-3-methoxy- benzyl)-zimtsäeureamide und deren verwendung zur herstellung von arzneimitteln | |
| SG141463A1 (en) | 2-(1h-indolysulfanyl)-benzyl amine derivatives as ssri | |
| NO20061425L (no) | Kombinasjonen av en serotonin-reopptaksinbibitor og loxapin | |
| MXPA05010678A (es) | Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de recaptacion de serotonina. | |
| EA200870533A1 (ru) | Производные 3-(1н-индол-3-ил)индан-1-иламина для лечения депрессии и тревожности | |
| TW200716083A (en) | Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders | |
| TW200616637A (en) | Novel quinoxalinone norepinephrine reuptake inhibitors for the treatment of central nervous system disorders | |
| UA85198C2 (ru) | Производные морфолина как ингибиторы повторного поглощения норэпинефрина | |
| UA81472C2 (en) | 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors |